Cimpress (CMPR) Stock Valuation Check After Mixed Short And Long Term Returns

Recent performance snapshot

Cimpress (CMPR) has drawn attention after a mixed stretch in its share price, with the stock down about 2% over the past day and 6% over the past month, but up 22% over the past 3 months.

Over longer periods, total returns of 35% year to date and about 98% over the past year contrast with a 13% decline over five years, giving investors a wide range of outcomes to consider.

See our latest analysis for Cimpress.

The recent pullback, including a 1-month share price return of down 5.65%, comes after a sharp recovery phase. The 1-year total shareholder return of 97.86% signals strong momentum from a longer-term base.

If Cimpress has you rethinking where growth could come from next, it may be worth scanning opportunities in 20 top founder-led companies

With Cimpress trading at $88.88, an indicated intrinsic discount of about 65% and a roughly 25% gap to analyst targets, the key question is whether this is a genuine opportunity or whether the market already expects stronger growth.

Most Popular Narrative: 20.3% Undervalued

At a last close of $88.88 versus a narrative fair value of $111.50, Cimpress is framed as undervalued, with that gap hinging on improving profitability and cash generation.

The company's growing focus on acquiring and retaining high-value customers, coupled with rising per-customer lifetime value (LTV) from broader product adoption, should enhance both gross profit dollars and reduce acquisition and advertising costs as a percentage of revenue, driving stronger net margins over time.

Read the complete narrative. Read the complete narrative.

Want to see what underpins that margin story? The narrative leans heavily on steadier revenue growth, higher profit margins, and a different earnings multiple than today. The full model lays out the assumptions that have to line up for $111.50 to make sense.

Result: Fair Value of $111.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that upside story runs into risk if legacy print keeps shrinking faster than newer categories grow, or if high CapEx fails to lift margins and cash flow.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another angle on valuation

The narrative prices Cimpress at a fair value of $111.50 based on future earnings and margins, but current market ratios tell a different story. At a P/E of 47.3x versus 21.2x for the US Commercial Services industry and a fair ratio of 27.6x, the stock screens as expensive, which raises the question of whether the growth case fully offsets that valuation risk.

For a closer look at how these earnings multiples compare and what the fair ratio suggests the market could move toward over time, take a look at the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment split between opportunity and concern, this is a moment to move quickly, review the key data points yourself, and decide whether the trade off between upside and risk feels right. To see both sides of that picture in one place, start with the 2 key rewards and 3 important warning signs

Looking for more investment ideas?

If Cimpress has sharpened your focus, do not stop here. The next smart move is lining up a watchlist of fresh ideas before the crowd does.

• Target potential value opportunities early by scanning 44 high quality undervalued stocks that match strong fundamentals with prices that may not fully reflect them yet.
• Prioritise resilience by reviewing 70 resilient stocks with low risk scores that score well on financial strength and business stability.
• Get ahead of the market by checking the screener containing 20 high quality undiscovered gems that most investors are not paying attention to yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com